This section will contain updates from the pain industry.

Mass General, Fern Health Broaden Digital Collaboration for Pain Management

Boston-based Massachusetts General Hospital and Fern Health, a provider of digital programs for chronic pain, have expanded their collaboration, giving the company access to 10 million de-identified patient records to he...
Continue reading

Releviate Therapeutics Inks Exclusive License for Human Monoclonal Antibodies for Chronic Pain Indications

Releviate™ Therapeutics, a bio-pharmaceutical company addressing the needs of patients suffering from chronic pain, signs an exclusive license for two patent pending human monoclonal antibodies developed by researchers a...
Continue reading
Topics:

Largescale Real-World Migraine Study Solidifies Efficacy and Safety of Theranica’s Nerivio® Device

Theranica , a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced the publication of a new real-world post-marketing surveillance study in ...
Continue reading

U.S. FDA Approves Athena Bioscience's New Drug Application (NDA) for QDOLO™ (tramadol hydrochloride) Oral Solution

Athena Bioscience, LLC, a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved QDOLO™ (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indi...
Continue reading

Maker of Mask Designed to Treat Chronic Pain Raises $5.8M

Sana masks reduce brain imbalances using audiovisual stimulation that leads to greater relaxation. They look similar to a virtual reality headset and use audio stimulation through headphones and visual stimulation with l...
Continue reading

FDA Approves XARACOLL® (bupivacaine HCl) Implant, a Non-opioid, Drug-device Treatment Option for Acute Postsurgical Pain Relief for up to 24 Hours Following Open Inguinal Hernia Repair in Adults

XARACOLL is a unique, non-injectable drug-device combination in the form of a fully bioresorbable collagen implant containing bupivacaine hydrochloride. XARACOLL is placed directly into the surgical site during surgery a...
Continue reading

FDA Approves New Opioid for Intravenous Use in Hospitals, Other Controlled Clinical Settings

The U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and ...
Continue reading

FDA Approves Digital Health App for Chronic Pain Management

A new digital health tool has been approved by the U.S. Food and Drug Administration. The approval of the iOS-compatible application will enable individuals with chronic pain and movement disorders to receive personalize...
Continue reading

AAPM Welcomes Helixmith as its Newest Corporate Relations Council Member

The AAPM Corporate Relations Council allows the Academy to partner with companies seeking new advances in the specialty of pain management and optimum quality of life for pain patients. AAPM is pleased to welcome Helixmi...
Continue reading

First Scientific Study Using Virtual Reality to Treat Chronic Pain at Home Finds AppliedVR Platform Feasible, Scalable and Effective

AppliedVR, announced results from the first randomized controlled trial (RCT), evaluating virtual-reality-based (VR) therapy for self-management of chronic pain at home. The study, which was published in JMIR-FR, found t...
Continue reading

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More